Rapid Minimal Residual Disease Clearance with More Stringent Age-Related Dose Criteria Improves Prognosis in Infants with KMT2A-Rearranged Acute Lymphoblastic Leukemia

被引：0

作者：

Ishihara, T. ^{[1
]}

Arakawa, Y. ^{[2
]}

Miyamura, T. ^{[3
]}

Nogami, Y. ^{[4
]}

Ishimaru, S. ^{[4
,5
]}

Takachi, T. ^{[6
]}

Yano, M. ^{[7
]}

Sasaki, S. ^{[8
]}

Saito, A. ^{[9
]}

Deguchi, T. ^{[10
]}

Hori, T. ^{[11
]}

Yamada, T. ^{[9
]}

Sanada, M. ^{[9
]}

Manabe, A. ^{[12
]}

Horibe, K.

Imamura, T. ^{[13
]}

Tomizawa, D. ^{[10
]}

机构：

[1] Nara Med Univ, Dept Pediat, Kashihara, Nara, Japan

[2] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan

[3] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka, Japan

[4] Natl Canc Ctr, Dept Pediat Oncol, Tokyo, Japan

[5] Princess Maxima Ctr Pediat Oncol, Trial & Data Ctr, Utrecht, Netherlands

[6] Shizuoka Childrens Hosp, Dept Hematol & Oncol, Shizuoka, Japan

[7] Kyoto City Hosp, Dept Pediat, Kyoto, Japan

[8] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori, Japan

[9] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan

[10] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan

[11] Aichi Med Univ, Dept Pediat, Nagakute, Aichi, Japan

[12] Hokkaido Univ, Dept Pediat, Sapporo, Hokkaido, Japan

[13] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan

来源：

PEDIATRIC BLOOD & CANCER | 2021年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O0178

引用

页码：S89 / S89

页数：1

共 37 条

[1] Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia
Burmeister, Thomas
Stroeh, Aeint-Steffen
Kehden, Britta
Trautmann, Heiko
Meyer, Claus
Marschalek, Rolf
Larghero, Patrizia
Schwartz, Stefan
Steffen, Bjoern
Spriewald, Bernd
Heinicke, Thomas
Jaekel, Nadja
Westermann, Joerg
Nachtkamp, Kathrin
Viardot, Andreas
Topp, Max S.
Neumann, Martin
Baldus, Claudia D.
Goekbuget, Nicola
Brueggemann, Monika
LEUKEMIA, 2024, 38 (07) : 1600 - 1603
[2] Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
Stutterheim, Janine
van der Sluis, Inge M.
de Lorenzo, Paola
Alten, Julia
Ancliffe, Philip
Attarbaschi, Andishe
Brethon, Benoit
Biondi, Andrea
Campbell, Myriam
Cazzaniga, Giovanni
Escherich, Gabriele
Ferster, Alina
Kotecha, Rishi S.
Lausen, Birgitte
Li, Chi Kong
Lo Nigro, Luca
Locatelli, Franco
Marschalek, Rolf
Meyer, Claus
Schrappe, Martin
Stary, Jan
Vora, Ajay
Zuna, Jan
van der Velden, Vincent H. J.
Szczepanski, Tomasz
Valsecchi, Maria Grazia
Pieters, Rob
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) : 652 - +
[3] Clinical Implications of Minimal Residual Disease Detection in Infants with KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
Stutterheim, Janine
van der Sluis, Inge M.
De Lorenzo, Paola
Alten, Julia
Ancliff, Philip
Attarbaschi, Andishe
Brethon, Benoit
Biondi, Andrea
Campbell, Myriam
Cazzaniga, Giovanni
Escherich, Gabriele
Ferster, Alina
Kotecha, Rishi Sury
Lausen, Birgitte
Li, Chi Kong
Lo Nigro, Luca
Locatelli, Franco
Marschalek, Rolf
Schrappe, Martin
Stary, Jan
Vora, Ajay
Zuna, Jan
Van der Velden, Vincent H. J.
Szczepanski, Tomasz
Valsecchi, Maria Grazia
Pieters, Rob
BLOOD, 2020, 136
[4] Important Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol
Stutterheim, J.
Van der Sluis, I.
De Lorenzo, P.
Ancliffe, P.
Aversa, L. A.
Brethon, B.
Biondi, A.
Campbell, M.
Escherich, G.
Ferster, A.
Gardner, R.
Kotecha, R. S.
Lausen, B.
Li, C. K.
Locatelli, F.
Attarbaschi, A.
Peters, C.
Rubnitz, J.
Silverman, L.
Stary, J.
Vora, A.
Schrappe, M.
Valsecchi, M.
Szczepanski, T.
Pieters, R.
PEDIATRIC BLOOD & CANCER, 2020, 67 : S2 - S3
[5] Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol (vol 39, pg 652, 2021)
Singh, N.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (30)
[6] Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631
Faulk, Kelly E.
Kairalla, John A.
Dreyer, ZoAnn E.
Carroll, Andrew J.
Heerema, Nyla A.
Devidas, Meenakshi
Carroll, William L.
Raetz, Elizabeth A.
Loh, Mignon L.
Hunger, Stephen P.
Borowitz, Michael
Wang, Cindy
Guest, Erin
Brown, Patrick A.
PEDIATRIC BLOOD & CANCER, 2023, 70 (09)
[7] Prognostic value of minimal residual disease measured by fusion-gene transcript in infants with KMT2A-rearranged acute lymphoblastic leukaemia treated according to the MLL-Baby protocol
Tsaur, Grigory
Popov, Alexander
Riger, Tatiana
Kustanovich, Anatoly
Solodovnikov, Alexander
Shorikov, Egor
Demina, Anna
Verzhbitskaya, Tatiana
Streneva, Olga
Makarova, Olga
Lapotentova, Elena
Aleinikova, Olga
Miakova, Natalia
Boichenko, Elmira
Kondratchik, Konstantin
Ponomareva, Natalia
Karachunskiy, Alexander
Roumiantsev, Alexander
Fechina, Larisa
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (06) : 1151 - 1156
[8] Minimal Residual Disease (MRD) Predicts Outcomes in KMT2A-Rearranged But Not KMT2A-Wild Type Infant Acute Lymphoblastic Leukemia (ALL): AALL0631, A Children's Oncology Group Study
Brown, P.
Kairalla, J.
Hilden, J.
Dreyer, Z.
Carroll, A.
Heerema, N. A.
Devidas, M.
Carroll, W.
Raetz, E.
Loh, M.
Hunger, S.
Borowitz, M.
PEDIATRIC BLOOD & CANCER, 2019, 66 : S28 - S29
[9] The role of constitutive activation of FMS-related tyrosine kinase-3 and NRas/KRas mutational status in infants with KMT2A-rearranged acute lymphoblastic leukemia
Fedders, Henning
Alsadeq, Ameera
Schmaeh, Juliane
Vogiatzi, Fotini
Zimmermann, Martin
Moericke, Anja
Lenk, Lennart
zur Stadt, Udo
Horstmann, Martin A.
Pieters, Rob
Schrappe, Martin
Stanulla, Martin
Cario, Gunnar
Schewe, Denis M.
HAEMATOLOGICA, 2017, 102 (11) : E438 - E442
[10] Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia
Sarkar, Sanila
Rav, Emily
Stitzlein, Lea
Gibson, Amber
Mccall, David
Nunez, Cesar
Roth, Michael
Ragoonanan, Dristhi
Connors, Jeremy
Herzog, Cynthia E.
Cuglievan, Branko
Garcia, Miriam B.
PEDIATRIC BLOOD & CANCER, 2024, 71 (06)

← 1 2 3 4 →